BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18091576)

  • 1. Arachidonic Acid metabolites in the cardiovascular system: the role of lipoxygenase isoforms in atherogenesis with particular emphasis on vascular remodeling.
    Kuhn H; Chaitidis P; Roffeis J; Walther M
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):609-20. PubMed ID: 18091576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic relevance of lipoxygenase isoforms in atherogenesis.
    Kuhn H
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1099-110. PubMed ID: 16293000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of lipoxygenase-isoforms in atherogenesis.
    Kühn H; Römisch I; Belkner J
    Mol Nutr Food Res; 2005 Nov; 49(11):1014-29. PubMed ID: 16270276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural biology of mammalian lipoxygenases: enzymatic consequences of targeted alterations of the protein structure.
    Kuhn H; Saam J; Eibach S; Holzhütter HG; Ivanov I; Walther M
    Biochem Biophys Res Commun; 2005 Dec; 338(1):93-101. PubMed ID: 16168952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders.
    Phillis JW; Horrocks LA; Farooqui AA
    Brain Res Rev; 2006 Sep; 52(2):201-43. PubMed ID: 16647138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoxygenase metabolism: roles in tumor progression and survival.
    Pidgeon GP; Lysaght J; Krishnamoorthy S; Reynolds JV; O'Byrne K; Nie D; Honn KV
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):503-24. PubMed ID: 17943411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selenium and the activities of cyclooxygenase and lipoxygenase in cells involved in atherogenesis].
    Serwatka K; Stachowska E; Chlubek D
    Ann Acad Med Stetin; 2005; 51(2):65-8. PubMed ID: 16519099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newly developed angiotensin II-infused experimental models in vascular biology.
    Qin Z
    Regul Pept; 2008 Oct; 150(1-3):1-6. PubMed ID: 18562020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arachidonic acid metabolites in the cardiovascular system.
    Feinmark SJ
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):467-9. PubMed ID: 18030054
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural properties of plant and mammalian lipoxygenases. Temperature-dependent conformational alterations and membrane binding ability.
    Mei G; Di Venere A; Nicolai E; Angelucci CB; Ivanov I; Sabatucci A; Dainese E; Kuhn H; Maccarrone M
    Biochemistry; 2008 Sep; 47(35):9234-42. PubMed ID: 18693758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins.
    Hersberger M
    Clin Chem Lab Med; 2010 Aug; 48(8):1063-73. PubMed ID: 20441482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular enzymology of lipoxygenases.
    Ivanov I; Heydeck D; Hofheinz K; Roffeis J; O'Donnell VB; Kuhn H; Walther M
    Arch Biochem Biophys; 2010 Nov; 503(2):161-74. PubMed ID: 20801095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mediator function of molecular factors--lipoxygenase enzyme systems during exposure to ionizing radiation].
    Budnitskaia EV
    Radiobiologiia; 1986; 26(4):435-46. PubMed ID: 3018832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechano-pathobiology of atherogenesis: a review.
    Vanepps JS; Vorp DA
    J Surg Res; 2007 Sep; 142(1):202-17. PubMed ID: 17612564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives.
    Cipollone F; Cicolini G; Bucci M
    Pharmacol Ther; 2008 May; 118(2):161-80. PubMed ID: 18420277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of epoxyeicosatrienoic acids in vascular regulation and cardiac preconditioning.
    Gauthier KM; Yang W; Gross GJ; Campbell WB
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):601-8. PubMed ID: 18091575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular remodeling: hemodynamic and biochemical mechanisms underlying Glagov's phenomenon.
    Korshunov VA; Schwartz SM; Berk BC
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1722-8. PubMed ID: 17541029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology of atherosclerotic plaques: what we are learning from proteomic analysis.
    Blanco-Colio LM; Martín-Ventura JL; Vivanco F; Michel JB; Meilhac O; Egido J
    Cardiovasc Res; 2006 Oct; 72(1):18-29. PubMed ID: 16814757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular biology of eicosanoids and atherogenesis.
    Praticò D; Dogné JM
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1079-89. PubMed ID: 19764861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.